QQQ   418.51 (-1.16%)
AAPL   164.93 (-1.26%)
MSFT   401.43 (-0.70%)
META   487.94 (-2.76%)
GOOGL   154.59 (-0.91%)
AMZN   176.06 (-1.76%)
TSLA   149.62 (-0.21%)
NVDA   818.41 (-3.34%)
AMD   150.06 (-3.24%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.29 (-0.24%)
F   12.11 (+0.41%)
MU   107.65 (-3.82%)
GE   150.59 (-1.54%)
CGC   7.74 (-1.15%)
DIS   111.76 (-0.60%)
AMC   3.08 (+5.48%)
PFE   25.75 (+1.42%)
PYPL   62.02 (-0.13%)
XOM   120.13 (+1.36%)
QQQ   418.51 (-1.16%)
AAPL   164.93 (-1.26%)
MSFT   401.43 (-0.70%)
META   487.94 (-2.76%)
GOOGL   154.59 (-0.91%)
AMZN   176.06 (-1.76%)
TSLA   149.62 (-0.21%)
NVDA   818.41 (-3.34%)
AMD   150.06 (-3.24%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.29 (-0.24%)
F   12.11 (+0.41%)
MU   107.65 (-3.82%)
GE   150.59 (-1.54%)
CGC   7.74 (-1.15%)
DIS   111.76 (-0.60%)
AMC   3.08 (+5.48%)
PFE   25.75 (+1.42%)
PYPL   62.02 (-0.13%)
XOM   120.13 (+1.36%)
QQQ   418.51 (-1.16%)
AAPL   164.93 (-1.26%)
MSFT   401.43 (-0.70%)
META   487.94 (-2.76%)
GOOGL   154.59 (-0.91%)
AMZN   176.06 (-1.76%)
TSLA   149.62 (-0.21%)
NVDA   818.41 (-3.34%)
AMD   150.06 (-3.24%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.29 (-0.24%)
F   12.11 (+0.41%)
MU   107.65 (-3.82%)
GE   150.59 (-1.54%)
CGC   7.74 (-1.15%)
DIS   111.76 (-0.60%)
AMC   3.08 (+5.48%)
PFE   25.75 (+1.42%)
PYPL   62.02 (-0.13%)
XOM   120.13 (+1.36%)
QQQ   418.51 (-1.16%)
AAPL   164.93 (-1.26%)
MSFT   401.43 (-0.70%)
META   487.94 (-2.76%)
GOOGL   154.59 (-0.91%)
AMZN   176.06 (-1.76%)
TSLA   149.62 (-0.21%)
NVDA   818.41 (-3.34%)
AMD   150.06 (-3.24%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.29 (-0.24%)
F   12.11 (+0.41%)
MU   107.65 (-3.82%)
GE   150.59 (-1.54%)
CGC   7.74 (-1.15%)
DIS   111.76 (-0.60%)
AMC   3.08 (+5.48%)
PFE   25.75 (+1.42%)
PYPL   62.02 (-0.13%)
XOM   120.13 (+1.36%)
Free Trial
NASDAQ:ZBIO

ProShares UltraPro Short Nasdaq Biotechnology (ZBIO) Price, Holdings, & News

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)
Free ZBIO Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$10.09
▼
$10.09
50-Day Range
$10.02
▼
$10.09
52-Week Range
$8.28
▼
$18.64
Volume
N/A
Average Volume
32,378 shs
Market Capitalization
$2.52 million
Assets Under Management
$2.85 million
Dividend Yield
0.30%
Net Expense Ratio
0.95%
Stock Analysis
Stock Analysis

ZBIO ETF News Headlines

February 25, 2023 | benzinga.com
Bullfrog AI Hldgs Stock (NASDAQ:BFRG), Quotes and News Summary
February 16, 2023 | morningstar.com
ProFunds Short NASDAQ-100 Svc
April 19, 2024 | InvestorPlace (Ad)
New crypto project uncovers 2,050% in 65 days
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
September 17, 2022 | wsj.com
Nasdaq Biotechnology Index NBI
August 23, 2022 | ca.finance.yahoo.com
ProShares UltraPro Short Nasdaq Biotechnology (ZBIO)
See More Headlines
Receive ZBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProShares UltraPro Short Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
ProShares
Fund Name
ProShares UltraPro Short Nasdaq Biotechnology
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:ZBIO
Inception Date
6/22/2015
Fund Manager
Michael Neches, Tarak Dave
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
NASDAQ Biotechnology Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
0

Fund Statistics

Assets Under Management
$2.85 million
Average Daily Volume
$25,501.70
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
J.P. Morgan Investor Services Co.
Advisor
ProShare Advisors LLC
Custodian
JPMorgan Chase Bank, N.A.
Distributor
SEI Investments Distribution Co.
Transfer Agent
JPMorgan Chase Bank, N.A.
Trustee
N/A
Lead Market Maker
Virtu Financial

Miscellaneous

Outstanding Shares
250,000
Beta
N/A
A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report
Ad InvestorPlace
New crypto project uncovers 2,050% in 65 days
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
Just click here to sign up and be among the first to get it.

ProShares UltraPro Short Nasdaq Biotechnology Expenses

TypeZBIOHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.75%0.56%0.54%0.48%0.51%
Other Expenses1.02%0.40%0.54%0.34%0.58%
Total Expense1.77%0.72%0.70%0.58%0.70%
Fee Waiver-0.82%-0.53%-0.55%-0.22%-0.57%
Net Expense0.95%0.60%0.60%0.54%0.58%

ProShares UltraPro Short Nasdaq Biotechnology (ZBIO)

Full Holdings Details

ZBIO ETF - Frequently Asked Questions

What does ZBIO invest in?

ProShares UltraPro Short Nasdaq Biotechnology is a equity fund issued by ProShares. ZBIO focuses on health care investments and follows the NASDAQ Biotechnology Index. The fund's investments total to approximately $2.85 million assets under management.

What is the management fee for ProShares UltraPro Short Nasdaq Biotechnology?

ProShares UltraPro Short Nasdaq Biotechnology's management fee is 0.75% and has other expenses of 1.02%. However, ZBIO has a fee waiver of -0.82% to reimburse the expenses. The net expense ratio for ZBIO is 0.95%.

What other stocks do shareholders of ProShares UltraPro Short Nasdaq Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares UltraPro Short Nasdaq Biotechnology investors own include ProShares UltraPro Short QQQ (SQQQ), ProShares UltraPro QQQ (TQQQ), Immunomedics (IMMU), Direxion Daily S&P Biotech Bear 3x Shares (LABD), Direxion Daily S&P Biotech Bull 3x Shares (LABU), Direxion Daily Semiconductors Bull 3x Shares (SOXL), Direxion Daily Small Cap Bull 3X Shares (TNA), Direxion Daily Small Cap Bear 3X Shares (TZA), Verizon Communications (VZ) and Eaton Vance Tax-Managed Buy-Write Opportunities Fund (ETV).

This page (NASDAQ:ZBIO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Urgent alert: open this for a huge profit potential
Timothy Sykes